Lupin Q2


'Lupin Q2' - 5 News Result(s)

  • Lupin Profit At Rs 266 Crore In September Quarter, Misses Analysts' Estimates

    Lupin Profit At Rs 266 Crore In September Quarter, Misses Analysts' Estimates

    Net profit was 266 crore ($36.00 million) in the quarter ended September 30, compared with a profit of Rs 455 crore a year earlier, Lupin said.

  • Lupin Q2 Profit Lags Estimates on Fewer Drug Launches

    Lupin Q2 Profit Lags Estimates on Fewer Drug Launches

    Lupin Ltd, India's third largest drug maker by sales, hopes to win approvals for some key products in its largest market, the United States, by the end of this year, after fewer product launches pushed second-quarter profit below estimates.

  • Lupin Q2 Meets Estimates, Net Grows 55%

    Lupin Q2 Meets Estimates, Net Grows 55%

    Lupin's US business, which contributes over 40 per cent to its total revenues, grew 23 per cent y-o-y to Rs 1,272 crore, while its India business which contributes the second highest revenue after US grew 20 per cent y-o-y to Rs 799 crore.

  • Lupin Q2 net profit rises 40 per cent to Rs 406 crore

    Lupin Q2 net profit rises 40 per cent to Rs 406 crore

    Drug major Lupin posted a nearly 40 per cent rise in consolidated net profit at Rs 406.20 crore for the quarter ended September 30, 2013-14 on account of robust sales in the US market.

  • Lupin Q2 net profit up 24% at Rs 266.9 crore

    Drug firm Lupin on Wednesday said its consolidated net profit rose by 24.13 per cent to Rs 266.9 crore in the second quarter ended September 30, on the back of robust sales growth across all the geographies, including the US and Japan. The company had posted a net profit of Rs 215 crore for the same period last fiscal, Lupin said in a statem...

'Lupin Q2' - 5 News Result(s)

  • Lupin Profit At Rs 266 Crore In September Quarter, Misses Analysts' Estimates

    Lupin Profit At Rs 266 Crore In September Quarter, Misses Analysts' Estimates

    Net profit was 266 crore ($36.00 million) in the quarter ended September 30, compared with a profit of Rs 455 crore a year earlier, Lupin said.

  • Lupin Q2 Profit Lags Estimates on Fewer Drug Launches

    Lupin Q2 Profit Lags Estimates on Fewer Drug Launches

    Lupin Ltd, India's third largest drug maker by sales, hopes to win approvals for some key products in its largest market, the United States, by the end of this year, after fewer product launches pushed second-quarter profit below estimates.

  • Lupin Q2 Meets Estimates, Net Grows 55%

    Lupin Q2 Meets Estimates, Net Grows 55%

    Lupin's US business, which contributes over 40 per cent to its total revenues, grew 23 per cent y-o-y to Rs 1,272 crore, while its India business which contributes the second highest revenue after US grew 20 per cent y-o-y to Rs 799 crore.

  • Lupin Q2 net profit rises 40 per cent to Rs 406 crore

    Lupin Q2 net profit rises 40 per cent to Rs 406 crore

    Drug major Lupin posted a nearly 40 per cent rise in consolidated net profit at Rs 406.20 crore for the quarter ended September 30, 2013-14 on account of robust sales in the US market.

  • Lupin Q2 net profit up 24% at Rs 266.9 crore

    Drug firm Lupin on Wednesday said its consolidated net profit rose by 24.13 per cent to Rs 266.9 crore in the second quarter ended September 30, on the back of robust sales growth across all the geographies, including the US and Japan. The company had posted a net profit of Rs 215 crore for the same period last fiscal, Lupin said in a statem...

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................